Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,265.39
(
0.33%
)
News Focus
News Focus

Replies to post #5 on Argenx SE (ARGX)

Replies to #5 on Argenx SE (ARGX)
icon url

riche

10/02/18 4:02 AM

#6 RE: riche #5

1-4 Dec 2018: Efgartigimod full Phase II ITP data, ARGX-110 full Phase I AML dose-escalation data, ARGX-110 full Phase II CTCL data YE 2018: launch of Phase III MG trial with Efgartigimod.